falseQ30001715925April 300001715925ipa:BioclueB.vMember2023-05-012024-01-310001715925ipa:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2024-01-310001715925ipa:AccumulatedAmortizationMember2022-04-300001715925ipa:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-04-300001715925ipa:OptionSixMember2024-01-310001715925ipa:CertificationsMemberipa:NetBookValueMember2023-04-300001715925srt:NorthAmericaMemberipa:CorporateSegmentsMember2023-04-300001715925ipa:IdeaFamilyB.vMember2022-05-012023-04-300001715925ifrs-full:GrossCarryingAmountMember2023-04-300001715925ifrs-full:GrossCarryingAmountMemberipa:ProprietaryProcessesMember2023-05-012024-01-3100017159252024-01-310001715925country:NL2023-05-012024-01-310001715925ipa:CertificationsMemberipa:AccumulatedAmortizationMember2022-05-012023-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2022-05-012023-04-300001715925ifrs-full:BuildingsMemberipa:AccumulatedDepreciationAmountMember2022-05-012023-04-300001715925ipa:AccumulatedAmortizationMemberipa:ProprietaryProcessesMember2022-04-3000017159252022-05-012023-04-300001715925ipa:NetBookValueMemberipa:ComputerHardwareMember2024-01-310001715925ipa:CryoStorageMember2023-05-012024-01-310001715925ifrs-full:IssuedCapitalMember2023-11-012024-01-310001715925srt:NorthAmericaMemberipa:CorporateSegmentsMember2024-01-310001715925srt:DirectorMemberipa:NineteenFebruaryTwentyTwentyThreeMember2023-05-012024-01-310001715925ipa:AccumulatedAmortizationMemberipa:InternallyGeneratedDevelopmentCostsMember2024-01-310001715925ipa:CertificationsMemberipa:AccumulatedAmortizationMember2022-04-300001715925ipa:ImmunoPreciseAntibodiesEuropeBVIPAEuropeFormerlyModiQuestResearchBVMember2023-05-012024-01-310001715925ipa:NetBookValueMemberipa:AutomobileMember2024-01-310001715925country:BE2023-05-012024-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberipa:ComputerHardwareMember2023-05-012024-01-310001715925ipa:AccumulatedDepreciationAmountMemberifrs-full:VehiclesMember2022-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2022-05-012023-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:VehiclesMember2023-05-012024-01-310001715925ifrs-full:RetainedEarningsMember2023-11-012024-01-310001715925ifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2024-01-310001715925ipa:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2023-05-012024-01-310001715925ifrs-full:GrossCarryingAmountMemberipa:WorkInProgressLeaseholdImrpvementsMember2022-05-012023-04-300001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-10-310001715925srt:NorthAmericaMember2023-04-300001715925ipa:NineteenJanuaryTwentyTwentyFourMemberipa:DirectorsOneMember2024-01-310001715925ipa:NineteenJanuaryTwentyTwentyFourMembersrt:DirectorMember2024-01-310001715925ifrs-full:AdditionalPaidinCapitalMember2024-01-310001715925ipa:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2022-05-012023-01-310001715925ipa:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-04-300001715925ifrs-full:GrossCarryingAmountMemberipa:CustomerListMember2024-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2023-05-012024-01-310001715925ifrs-full:GrossCarryingAmountMember2022-05-012023-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2023-05-012024-01-310001715925ipa:ImmunoPreciseNetherlandsBVMember2022-05-012023-04-300001715925ifrs-full:GrossCarryingAmountMemberipa:LabEquipmentMember2022-05-012023-04-300001715925country:BE2022-11-012023-01-310001715925ipa:NetBookValueMemberipa:IntellectualPropertiesMember2024-01-310001715925ifrs-full:GrossCarryingAmountMemberipa:InternallyGeneratedDevelopmentCostsMember2024-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2022-05-012023-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberipa:WorkInProgressLeaseholdImrpvementsMember2023-05-012024-01-310001715925ipa:OptionFiveMember2024-01-310001715925country:US2023-05-012024-01-310001715925ifrs-full:GrossCarryingAmountMemberipa:LabEquipmentMember2022-04-300001715925ipa:ImmunoPreciseAntibodiesMALLCMember2022-05-012023-04-300001715925srt:NorthAmericaMember2024-01-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-05-012023-01-310001715925ipa:NetBookValueMemberipa:ComputerHardwareMember2023-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2023-04-300001715925ipa:OptionNineMember2024-01-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2024-01-310001715925ipa:NetBookValueMember2024-01-310001715925ifrs-full:BuildingsMemberipa:AccumulatedDepreciationAmountMember2024-01-310001715925ifrs-full:IssuedCapitalMember2023-05-012024-01-310001715925srt:NorthAmericaMemberipa:CorporateSegmentsMember2022-05-012023-01-310001715925ifrs-full:GrossCarryingAmountMemberipa:InternallyGeneratedDevelopmentCostsMember2023-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberipa:AutomobileMember2023-05-012024-01-310001715925ipa:ConvertibleDebenturesMember2022-05-012023-01-310001715925country:US2023-11-012024-01-310001715925ipa:OptionSixMember2023-05-012024-01-310001715925srt:NorthAmericaMember2023-11-012024-01-310001715925ifrs-full:BuildingsMemberifrs-full:GrossCarryingAmountMember2024-01-310001715925ifrs-full:LeaseLiabilitiesMember2023-01-310001715925ifrs-full:GrossCarryingAmountMemberipa:LabEquipmentMember2023-05-012024-01-310001715925ipa:AccumulatedDepreciationAmountMemberifrs-full:VehiclesMember2023-04-300001715925ifrs-full:GrossCarryingAmountMemberipa:ComputerHardwareMember2023-05-012024-01-310001715925ifrs-full:RetainedEarningsMember2022-10-310001715925ipa:FindersWarrantsMemberipa:RangeOneMember2023-05-012024-01-310001715925ipa:AccumulatedAmortizationMemberipa:CustomerListMember2022-04-300001715925ipa:AccumulatedAmortizationMemberipa:IntellectualPropertiesMember2022-05-012023-01-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-01-310001715925ifrs-full:BuildingsMemberifrs-full:GrossCarryingAmountMember2022-05-012023-04-300001715925country:CA2022-11-012023-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2024-01-310001715925ipa:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2024-01-310001715925ifrs-full:GrossCarryingAmountMemberipa:AutomobileMember2024-01-310001715925ipa:ImmunoPreciseAntibodiesUSALtdIPAUSAMember2023-05-012024-01-310001715925ipa:AccumulatedDepreciationAmountMemberipa:LabEquipmentMember2022-04-300001715925ipa:CertificationsMemberifrs-full:GrossCarryingAmountMember2023-05-012024-01-310001715925ipa:AccumulatedAmortizationMemberipa:IntellectualPropertiesMember2023-05-012024-01-310001715925ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2024-01-310001715925ifrs-full:RetainedEarningsMember2023-10-310001715925ipa:CertificationsMemberipa:AccumulatedAmortizationMember2024-01-310001715925ipa:AccumulatedDepreciationAmountMemberipa:LabEquipmentMember2022-05-012023-04-300001715925ifrs-full:LaterThanFiveYearsMember2024-01-310001715925ipa:OptionNineMember2023-05-012024-01-310001715925ifrs-full:IssuedCapitalMember2024-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:ComputerSoftwareMember2023-04-300001715925ipa:AccumulatedAmortizationMemberipa:ProprietaryProcessesMember2023-04-3000017159252022-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2022-04-300001715925ipa:OfficersAndEmployeesMemberipa:NineteenFebruaryTwentyTwentyThreeMember2023-05-012024-01-310001715925ipa:AccumulatedAmortizationMember2023-05-012024-01-310001715925country:AU2023-05-012024-01-310001715925ifrs-full:VehiclesMemberipa:NetBookValueMember2023-04-300001715925ipa:CertificationsMemberifrs-full:GrossCarryingAmountMember2024-01-310001715925ifrs-full:IssuedCapitalMember2023-10-310001715925ifrs-full:GrossCarryingAmountMemberipa:InternallyGeneratedDevelopmentCostsMember2023-05-012024-01-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-05-012024-01-310001715925ipa:CertificationsMemberifrs-full:GrossCarryingAmountMember2023-04-300001715925ipa:AccumulatedDepreciationAmountMember2022-05-012023-04-300001715925ipa:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-05-012023-04-300001715925ipa:AccumulatedAmortizationMemberipa:InternallyGeneratedDevelopmentCostsMember2023-05-012024-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberipa:AutomobileMember2022-05-012023-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2024-01-310001715925ipa:NetBookValueMemberipa:InternallyGeneratedDevelopmentCostsMember2023-04-300001715925ifrs-full:BuildingsMemberipa:AccumulatedDepreciationAmountMember2023-04-300001715925ifrs-full:IssuedCapitalMember2022-10-310001715925ifrs-full:GrossCarryingAmountMemberipa:ComputerHardwareMember2022-04-300001715925ifrs-full:BuildingsMemberipa:AccumulatedDepreciationAmountMember2022-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2022-04-300001715925ipa:AccumulatedAmortizationMemberipa:IntellectualPropertiesMember2022-04-300001715925ipa:AccumulatedDepreciationAmountMemberipa:LabEquipmentMember2024-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:VehiclesMember2022-04-300001715925ifrs-full:BuildingsMemberipa:NetBookValueMember2024-01-310001715925ifrs-full:GrossCarryingAmountMemberipa:AutomobileMember2023-04-300001715925ifrs-full:GrossCarryingAmountMemberipa:AutomobileMember2022-04-300001715925ipa:NetBookValueMemberipa:IntellectualPropertiesMember2023-04-300001715925ipa:AccumulatedDepreciationAmountMemberipa:LabEquipmentMember2023-05-012024-01-310001715925ipa:OptionTenMember2023-05-012024-01-310001715925ipa:NineteenJanuaryTwentyTwentyFourMemberipa:DirectorsOneMember2023-05-012024-01-310001715925ifrs-full:ReserveOfEquityComponentOfConvertibleInstrumentsMember2022-05-012023-01-310001715925ifrs-full:WeightedAverageMemberifrs-full:VehiclesMember2023-05-012024-01-310001715925ipa:NetBookValueMember2024-01-310001715925ipa:ImmunoPreciseAntibodiesEuropeBVIPAEuropeFormerlyModiQuestResearchBVMember2022-05-012023-04-300001715925ifrs-full:GrossCarryingAmountMemberipa:WorkInProgressLeaseholdImrpvementsMember2022-04-300001715925ipa:QuebecIncMember2023-05-012024-01-310001715925ifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-05-012023-04-300001715925ipa:LabAndOfficeFacilitiesMemberifrs-full:WeightedAverageMember2023-05-012024-01-310001715925ipa:ImmunoPreciseAntibodiesNDLtdMember2023-05-012024-01-310001715925ifrs-full:AdditionalPaidinCapitalMember2022-11-012023-01-310001715925ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2024-01-310001715925ifrs-full:AdditionalPaidinCapitalMember2023-05-012024-01-310001715925ipa:LabEquipmentMemberipa:NetBookValueMember2024-01-3100017159252022-05-310001715925country:NL2022-11-012023-01-310001715925ipa:OptionNineteenMember2023-05-012024-01-310001715925country:BE2024-01-310001715925ifrs-full:AdditionalPaidinCapitalMember2023-01-310001715925ipa:NetBookValueMemberipa:CertificationsMember2024-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2022-05-012023-04-300001715925ifrs-full:ReserveOfEquityComponentOfConvertibleInstrumentsMember2022-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-04-300001715925ifrs-full:LeaseLiabilitiesMember2023-04-300001715925ipa:CertificationsMemberifrs-full:GrossCarryingAmountMember2022-05-012023-01-310001715925ipa:AccumulatedDepreciationAmountMember2023-05-012024-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2023-05-012024-01-310001715925ifrs-full:GrossCarryingAmountMember2024-01-310001715925ipa:ConvertibleDebenturesMember2022-04-300001715925ifrs-full:ComputerSoftwareMemberipa:NetBookValueMember2023-04-300001715925ipa:DeferredAcquisitionPaymentsMember2023-05-012024-01-310001715925ifrs-full:BuildingsMemberipa:NetBookValueMember2023-04-300001715925ipa:NetBookValueMemberipa:AutomobileMember2023-04-300001715925ipa:FifteenMayTwentyTwentyTwoMemberipa:EmployeesMember2024-01-310001715925ipa:AccumulatedDepreciationAmountMemberipa:LabEquipmentMember2023-04-300001715925ipa:AccumulatedAmortizationMemberipa:InternallyGeneratedDevelopmentCostsMember2022-05-012023-01-310001715925ifrs-full:TopOfRangeMemberifrs-full:VehiclesMember2023-05-012024-01-310001715925ifrs-full:GrossCarryingAmountMemberipa:LabEquipmentMember2023-04-300001715925ipa:DeferredAcquisitionPaymentsMember2023-01-310001715925ifrs-full:VehiclesMemberifrs-full:GrossCarryingAmountMember2022-05-012023-04-300001715925ipa:WorkInProgressLeaseholdImrpvementsMemberipa:NetBookValueMember2023-04-300001715925ipa:NetBookValueMemberifrs-full:LeaseholdImprovementsMember2024-01-310001715925ifrs-full:RetainedEarningsMember2022-05-012023-01-310001715925srt:EuropeMember2023-05-012024-01-310001715925ipa:DeferredAcquisitionPaymentsMember2022-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2023-05-012024-01-310001715925ipa:ImmunoPreciseAntibodiesMALLCMember2023-05-012024-01-310001715925country:CA2023-05-012024-01-310001715925ifrs-full:GrossCarryingAmountMemberipa:ComputerHardwareMember2022-05-012023-04-300001715925ipa:AccumulatedDepreciationAmountMemberifrs-full:VehiclesMember2024-01-310001715925ipa:BioclueB.vMember2022-05-012023-04-300001715925ipa:NetBookValueMember2023-04-300001715925country:CA2023-11-012024-01-310001715925ipa:AllOtherCountriesMember2023-11-012024-01-310001715925ipa:ProjectRevenueMember2023-11-012024-01-310001715925ifrs-full:IssuedCapitalMember2023-01-310001715925country:BE2023-11-012024-01-310001715925ipa:ProjectRevenueMember2022-05-012023-01-310001715925ipa:ImmunoPreciseAntibodiesCanadaLtdMember2023-05-012024-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2024-01-310001715925ifrs-full:GrossCarryingAmountMember2022-05-012023-01-310001715925country:NL2023-04-300001715925ipa:DeferredAcquisitionPaymentsMember2022-05-012023-01-310001715925ifrs-full:NotLaterThanOneYearMember2024-01-310001715925ifrs-full:PotentialOrdinaryShareTransactionsMemberipa:AtTheMarketEquityOfferingFacilityMember2024-03-132024-03-130001715925ipa:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-05-012024-01-310001715925ipa:OptionTwelveMember2024-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2023-04-300001715925ifrs-full:GrossCarryingAmountMemberipa:CustomerListMember2022-04-3000017159252023-10-310001715925ifrs-full:BuildingsMemberifrs-full:GrossCarryingAmountMember2023-04-300001715925ipa:NetBookValueMemberipa:CustomerListMember2024-01-310001715925ipa:ImmunoPreciseAntibodiesQuebecLtdMember2023-05-012024-01-310001715925ipa:AccumulatedDepreciationAmountMember2022-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2022-05-012023-04-300001715925ipa:ImmunoPreciseNetherlandsBVMember2023-05-012024-01-310001715925ifrs-full:GrossCarryingAmountMemberipa:WorkInProgressLeaseholdImrpvementsMember2023-04-300001715925ipa:OptionNineteenMember2024-01-310001715925ifrs-full:LeaseLiabilitiesMember2024-01-310001715925ifrs-full:VehiclesMemberifrs-full:GrossCarryingAmountMember2023-04-300001715925ipa:AccumulatedAmortizationMemberipa:InternallyGeneratedDevelopmentCostsMember2023-04-300001715925ipa:BiostrandMember2024-01-310001715925ipa:NetBookValueMemberifrs-full:FixturesAndFittingsMember2024-01-310001715925ipa:ImmunoPreciseAntibodiesUSALtdIPAUSAMember2022-05-012023-04-300001715925ipa:AccumulatedAmortizationMemberipa:CustomerListMember2023-04-300001715925ifrs-full:LeaseLiabilitiesMember2022-05-012023-01-310001715925ifrs-full:GrossCarryingAmountMember2023-05-012024-01-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2023-04-300001715925ipa:AllOtherCountriesMember2022-05-012023-01-310001715925ipa:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2022-04-300001715925ipa:ImmunoPreciseAntibodiesCanadaLtdMember2022-05-012023-04-300001715925ifrs-full:GrossCarryingAmountMemberipa:LabEquipmentMember2023-04-300001715925ifrs-full:GrossCarryingAmountMemberipa:LabEquipmentMember2024-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberipa:WorkInProgressLeaseholdImrpvementsMember2023-04-300001715925ifrs-full:IssuedCapitalMember2022-04-300001715925ipa:TalemTherapeuticsLLCTalemMember2023-05-012024-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberipa:AutomobileMember2024-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberipa:AutomobileMember2022-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2022-04-300001715925ipa:AccumulatedAmortizationMemberipa:ProprietaryProcessesMember2022-05-012023-01-310001715925ipa:OptionFourteenAndOptionFifteenMember2024-01-310001715925ipa:LabEquipmentMemberipa:NetBookValueMember2023-04-300001715925ifrs-full:GrossCarryingAmountMemberipa:AutomobileMember2022-05-012023-04-300001715925ipa:CryoStorageMember2022-11-012023-01-310001715925ipa:AccumulatedAmortizationMemberipa:CustomerListMember2023-05-012024-01-310001715925ipa:FifteenMayTwentyTwentyTwoMemberipa:EmployeesMember2023-05-012024-01-310001715925ifrs-full:GrossCarryingAmountMember2023-05-012024-01-310001715925ifrs-full:GrossCarryingAmountMemberipa:ComputerHardwareMember2023-04-300001715925country:BE2022-05-012023-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberipa:ComputerHardwareMember2022-04-300001715925ifrs-full:RetainedEarningsMember2023-01-310001715925ipa:BiostrandB.v.Member2022-05-012023-04-300001715925ifrs-full:VehiclesMemberifrs-full:GrossCarryingAmountMember2024-01-310001715925ifrs-full:AdditionalPaidinCapitalMember2023-11-012024-01-310001715925country:US2022-05-012023-01-310001715925ipa:AccumulatedDepreciationAmountMember2023-04-300001715925ifrs-full:GrossCarryingAmountMemberipa:ProprietaryProcessesMember2023-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2023-10-3100017159252023-05-012024-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2023-05-012024-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberipa:ComputerHardwareMember2024-01-310001715925ifrs-full:GrossCarryingAmountMemberipa:ProprietaryProcessesMember2024-01-310001715925ipa:OptionSevenMember2024-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberipa:ComputerHardwareMember2023-04-300001715925ipa:BiokeyB.vMember2022-05-012023-04-300001715925ipa:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2023-04-300001715925srt:NorthAmericaMember2022-11-012023-01-310001715925ipa:NetBookValueMemberifrs-full:BuildingsMember2023-04-300001715925ifrs-full:GrossCarryingAmountMember2022-04-300001715925ipa:WorkInProgressLeaseholdImrpvementsMemberipa:NetBookValueMember2024-01-310001715925ipa:OptionThirteenMember2024-01-310001715925ifrs-full:IssuedCapitalMember2022-11-012023-01-310001715925ifrs-full:GrossCarryingAmountMemberipa:LabEquipmentMember2024-01-310001715925ifrs-full:LeaseLiabilitiesMember2022-04-300001715925country:NL2023-11-012024-01-310001715925ipa:NetBookValueMemberifrs-full:BuildingsMember2024-01-310001715925ifrs-full:RetainedEarningsMember2023-04-300001715925country:NL2022-05-012023-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2023-04-300001715925ifrs-full:RetainedEarningsMember2022-04-300001715925ifrs-full:GrossCarryingAmountMember2022-04-300001715925ipa:LabAndOfficeFacilitiesMember2024-01-310001715925ifrs-full:LeaseLiabilitiesMember2023-05-012024-01-310001715925ifrs-full:GrossCarryingAmountMemberipa:ProprietaryProcessesMember2022-05-012023-01-310001715925ifrs-full:IssuedCapitalMember2023-04-300001715925ifrs-full:ComputerSoftwareMemberipa:NetBookValueMember2024-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:ComputerSoftwareMember2022-04-300001715925ifrs-full:RetainedEarningsMember2023-05-012024-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2023-04-300001715925ifrs-full:IssuedCapitalMember2022-05-012023-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2023-04-300001715925ifrs-full:OrdinarySharesMemberifrs-full:IssuedCapitalMember2022-05-012023-04-300001715925ifrs-full:GrossCarryingAmountMemberipa:InternallyGeneratedDevelopmentCostsMember2022-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2023-05-012024-01-310001715925ifrs-full:RetainedEarningsMember2024-01-310001715925ipa:AccumulatedAmortizationMemberipa:ProprietaryProcessesMember2024-01-310001715925ifrs-full:GrossCarryingAmountMemberipa:ProprietaryProcessesMember2022-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberipa:WorkInProgressLeaseholdImrpvementsMember2024-01-310001715925ifrs-full:TopOfRangeMemberifrs-full:PotentialOrdinaryShareTransactionsMemberipa:AtTheMarketEquityOfferingFacilityMember2024-02-232024-02-230001715925ipa:OptionThirteenMember2023-05-012024-01-310001715925country:AU2022-11-012023-01-310001715925ipa:ImmunoPreciseAntibodiesQuebecLtdMember2022-05-012023-04-300001715925ipa:AccumulatedDepreciationAmountMember2024-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2023-04-300001715925ipa:LabAndOfficeFacilitiesMemberifrs-full:TopOfRangeMember2023-05-012024-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2023-04-300001715925ipa:CryoStorageMember2023-11-012024-01-3100017159252021-05-012022-04-300001715925ipa:NetBookValueMemberipa:ProprietaryProcessesMember2024-01-310001715925ipa:OptionFourteenMember2023-05-012024-01-310001715925ipa:AccumulatedDepreciationAmountMemberifrs-full:VehiclesMember2023-05-012024-01-310001715925ifrs-full:GrossCarryingAmountMemberipa:CustomerListMember2023-05-012024-01-310001715925ipa:OptionFifteenMember2023-05-012024-01-310001715925ipa:AccumulatedAmortizationMemberipa:CustomerListMember2022-05-012023-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2023-05-012024-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2022-04-300001715925ipa:CertificationsMemberifrs-full:GrossCarryingAmountMember2022-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2024-01-310001715925ipa:AccumulatedAmortizationMember2022-05-012023-01-310001715925country:NL2024-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberipa:WorkInProgressLeaseholdImrpvementsMember2022-05-012023-04-300001715925ifrs-full:GrossCarryingAmountMemberipa:InternallyGeneratedDevelopmentCostsMember2022-05-012023-01-310001715925ipa:OptionTenMember2024-01-310001715925ipa:TalemTherapeuticsLLCTalemMember2022-05-012023-04-300001715925ipa:FindersWarrantsMemberipa:RangeOneMember2024-01-310001715925srt:NorthAmericaMemberipa:CorporateSegmentsMember2023-05-012024-01-310001715925ipa:ProductSalesMember2022-05-012023-01-310001715925ifrs-full:GrossCarryingAmountMemberipa:CustomerListMember2022-05-012023-01-310001715925ipa:AccumulatedAmortizationMemberipa:IntellectualPropertiesMember2023-04-300001715925ipa:OptionEighteenMember2024-01-310001715925ipa:AccumulatedAmortizationMemberipa:InternallyGeneratedDevelopmentCostsMember2022-04-300001715925ipa:NetBookValueMemberifrs-full:LeaseholdImprovementsMember2023-04-300001715925ifrs-full:GrossCarryingAmountMemberipa:ComputerHardwareMember2024-01-310001715925ipa:NetBookValueMemberipa:LabEquipmentMember2023-04-3000017159252022-10-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-11-012023-01-310001715925ipa:OptionFourteenMember2024-01-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-11-012024-01-310001715925srt:DirectorMemberipa:NineteenFebruaryTwentyTwentyThreeMember2024-01-310001715925ipa:ProductSalesMember2023-11-012024-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2022-04-300001715925ipa:OptionEighteenMember2023-05-012024-01-310001715925ifrs-full:VehiclesMemberifrs-full:BottomOfRangeMember2023-05-012024-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2024-01-3100017159252022-11-012023-01-310001715925ipa:NetBookValueMemberipa:InternallyGeneratedDevelopmentCostsMember2024-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2024-01-310001715925ipa:BiostrandB.v.Member2023-05-012024-01-310001715925srt:NorthAmericaMemberipa:CorporateSegmentsMember2023-11-012024-01-310001715925ifrs-full:BuildingsMemberipa:AccumulatedDepreciationAmountMember2023-05-012024-01-3100017159252023-04-300001715925ipa:OptionSevenMember2023-05-012024-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberipa:AutomobileMember2023-04-300001715925ipa:DeferredAcquisitionPaymentsMember2024-01-310001715925ipa:AccumulatedAmortizationMemberipa:CustomerListMember2024-01-3100017159252023-01-310001715925ifrs-full:GrossCarryingAmountMember2024-01-310001715925country:US2022-11-012023-01-310001715925ipa:OptionFiveMember2023-05-012024-01-310001715925ipa:CertificationsMemberipa:AccumulatedAmortizationMember2023-04-300001715925ifrs-full:BuildingsMemberifrs-full:GrossCarryingAmountMember2022-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2022-04-300001715925ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2024-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2022-05-012023-04-300001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-10-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-310001715925ipa:NetBookValueMemberipa:LabEquipmentMember2024-01-310001715925ipa:DeferredAcquisitionPaymentsMember2023-04-300001715925ipa:NetBookValueMemberifrs-full:FixturesAndFittingsMember2023-04-300001715925ipa:AccumulatedAmortizationMember2023-04-300001715925ipa:OssTheNetherlandsMember2023-05-012024-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2023-05-012024-01-310001715925ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember2024-01-310001715925country:AU2023-11-012024-01-310001715925srt:EuropeMember2023-11-012024-01-310001715925country:CA2022-05-012023-01-310001715925ipa:ImmunoPreciseAntibodiesNDLtdMember2022-05-012023-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2022-05-012023-04-300001715925ipa:BiokeyB.vMember2023-05-012024-01-3100017159252022-05-012023-01-310001715925srt:EuropeMember2022-05-012023-01-310001715925ifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-05-012024-01-310001715925ipa:NetBookValueMemberipa:CustomerListMember2023-04-300001715925ipa:NetBookValueMemberipa:ProprietaryProcessesMember2023-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2022-10-310001715925ifrs-full:GrossCarryingAmountMemberipa:WorkInProgressLeaseholdImrpvementsMember2023-05-012024-01-310001715925country:AU2022-05-012023-01-310001715925ifrs-full:GrossCarryingAmountMemberipa:AutomobileMember2023-05-012024-01-310001715925ipa:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2023-05-012024-01-310001715925ipa:OfficersAndEmployeesMemberipa:NineteenFebruaryTwentyTwentyThreeMember2024-01-310001715925ipa:LabAndOfficeFacilitiesMemberifrs-full:BottomOfRangeMember2023-05-012024-01-310001715925country:BE2023-04-300001715925ipa:NineteenJanuaryTwentyTwentyFourMembersrt:DirectorMember2023-05-012024-01-310001715925ipa:CertificationsMemberipa:AccumulatedAmortizationMember2023-05-012024-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2024-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-05-012023-04-300001715925ifrs-full:BuildingsMemberifrs-full:GrossCarryingAmountMember2023-05-012024-01-310001715925ifrs-full:GrossCarryingAmountMemberipa:LabEquipmentMember2022-04-300001715925ipa:AccumulatedDepreciationAmountMemberifrs-full:VehiclesMember2022-05-012023-04-300001715925ipa:AccumulatedAmortizationMemberipa:ProprietaryProcessesMember2023-05-012024-01-310001715925ipa:ConvertibleDebenturesMember2023-01-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberipa:WorkInProgressLeaseholdImrpvementsMember2022-04-300001715925ifrs-full:GrossCarryingAmountMemberipa:WorkInProgressLeaseholdImrpvementsMember2024-01-310001715925ipa:QuebecIncMember2022-05-012023-04-300001715925ipa:AllOtherCountriesMember2023-05-012024-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2022-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2023-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberipa:ComputerHardwareMember2022-05-012023-04-300001715925srt:NorthAmericaMember2023-05-012024-01-310001715925ipa:AccumulatedAmortizationMember2024-01-310001715925ifrs-full:AdditionalPaidinCapitalMember2022-05-012023-01-310001715925srt:EuropeMember2022-11-012023-01-310001715925ipa:OptionTwelveMember2023-05-012024-01-310001715925srt:NorthAmericaMember2022-05-012023-01-310001715925ipa:ProductSalesMember2023-05-012024-01-310001715925ipa:RangeTwoMemberipa:FindersWarrantsMember2024-01-310001715925ipa:NetBookValueMember2023-04-300001715925ifrs-full:VehiclesMemberipa:NetBookValueMember2024-01-310001715925ipa:OptionFifteenMember2024-01-310001715925ipa:CryoStorageMember2022-05-012023-01-310001715925ifrs-full:GrossCarryingAmountMember2023-04-300001715925ipa:ProjectRevenueMember2023-05-012024-01-310001715925ipa:ProjectRevenueMember2022-11-012023-01-310001715925ifrs-full:PotentialOrdinaryShareTransactionsMemberipa:AtTheMarketEquityOfferingFacilityMember2024-03-1300017159252023-11-012024-01-310001715925ifrs-full:OrdinarySharesMemberifrs-full:IssuedCapitalMember2023-04-300001715925ifrs-full:GrossCarryingAmountMemberipa:CustomerListMember2023-04-300001715925srt:NorthAmericaMemberipa:CorporateSegmentsMember2022-11-012023-01-310001715925ipa:AllOtherCountriesMember2022-11-012023-01-310001715925ipa:RangeTwoMemberipa:FindersWarrantsMember2023-05-012024-01-310001715925ipa:ProductSalesMember2022-11-012023-01-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2022-04-300001715925ifrs-full:RetainedEarningsMember2022-11-012023-01-310001715925ifrs-full:VehiclesMember2024-01-310001715925ipa:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2022-05-012023-04-300001715925ipa:AccumulatedAmortizationMemberipa:IntellectualPropertiesMember2024-01-310001715925ipa:IdeaFamilyB.vMember2023-05-012024-01-31iso4217:EURxbrli:pureipa:Leasexbrli:sharesipa:LeasedAssetiso4217:CADutr:Y
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of March, 2024.
Commission File Number: 001-39530
ImmunoPrecise Antibodies Ltd.
3204 - 4464 Markham Street, Victoria, British Columbia V8Z 7X8
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
INCORPORATION BY REFERENCE
Exhibits 99.1, 99.2, 101.INS, 101.SCH, and 104 of this Form 6-K are incorporated by reference into the Registration Statement on Form F-3 (File No. 333-273197) and Registration Statement on Form S-8 (File No. 333-256730) of the Registrant, ImmunoPrecise Antibodies Ltd.
EXHIBIT INDEX
|
|
101.INS |
Inline XBRL Instance Document–the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document |
101.SCH |
Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents |
104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
|
|
|
|
|
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
IMMUNOPRECISE ANTIBODIES LTD. |
Date: March 14, 2024 |
|
|
|
|
|
By: |
/s/ Kristin Taylor |
|
Name: |
Kristin Taylor |
|
Title: |
Chief Financial Officer |